Salud
Novartis recortará 680 puestos de trabajo en el desarrollo de productos
Novartis is to cut up to 680 jobs in its development organisation that helps bring its drugs to market, the Swiss drugmaker said. About 440
La inyección de Pfizer RSV alcanzó los objetivos en un estudio de adultos de alto riesgo menores de 60 años
Pfizer said Tuesday that its respiratory syncytial virus (RSV) vaccine, Abrisvo, is well tolerated and induces an immune response in high-risk adults under age 60,
La atención de género a los jóvenes es “débil”
The medical evidence underpinning gender care for adolescents is “remarkably weak” and offers little clarity on long-term outcomes, according to a state-funded NHS England study.
La inyección de Pfizer RSV alcanzó los objetivos en un estudio de adultos de alto riesgo menores de 60 años
Pfizer said Tuesday that its respiratory syncytial virus (RSV) vaccine, Abrisvo, is well tolerated and induces an immune response in high-risk adults under the age
La FDA de EE. UU. se niega nuevamente a aprobar la combinación Supernus para el Parkinson
Supernus Pharmaceuticals said the US FDA has refused to approve a drug and device combination to treat Parkinson’s disease’s movement-related symptoms, sending its shares down
Aumenta riesgo de epidemia de dengue en Argentina
Mosquitoes are hatching earlier in Argentina and reaching colder regions than before, as rising temperatures drive the country’s worst dengue outbreak. So far in the
Synchron prepara un ensayo de implante cerebral a gran escala
Synchron is preparing to recruit patients for a large-scale clinical trial needed to gain commercial approval for its device, the company’s chief executive told Reuters.
La empresa matriz de Novo Nordisk vuelve a presentar oferta estadounidense para el acuerdo con Catalent
The parent company of Wegovy maker Novo Nordisk has reapplied to the US Federal Trade Commission for approval of a $16.5bn deal to buy manufacturing
La vacuna Geneos contra el cáncer reduce los tumores hepáticos en un pequeño estudio
Nearly a third of patients with advanced liver cancer who received a personalised vaccine developed by Geneos Therapeutics along with an immunotherapy drug in a
La FDA de EE. UU. aprueba el uso ampliado de la terapia con células cancerosas de J&J
The US Food and Drug Administration has authorised the expanded use of Johnson & Johnson and Legend Biotech’s Carvicti cell therapy as an early treatment